Congress is unlikely to act on 340B in 2024, but a potential flip of the U.S. Senate could lead to [...] …
Category: Legislative
Tennessee state lawmakers have introduced companion bills that would require sexually transmitted disease (STD) clinics to enter into a contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Critics of hospital participation in the 340B discount drug program are ramping up efforts, as a bipartisan group of senators [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A former Trump administration Health and Human Service Department (HHS) executive and adviser to Sen. Bill Cassidy (R-LA) published a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
As we approach the 16-month mark since we had pivotal arguments over the 340B contract pharmacy program in two federal [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two high-ranking Republican Arizona state senators have introduced a bill that would bar drug manufacturer restrictions on 340B contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added two more [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Influential Republican lawmakers have introduced companion bills in the U.S. House and Senate that call for a government report on [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
New Medicaid Policy Change Could Reduce 340B Savings, Cause Drug Discontinuations, Warn Stakeholders
A Medicaid policy change that took effect at the start of 2024 could indirectly lead to lower 340B savings and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key healthcare committee in the Iowa House of Representatives recently introduced a bill that would bar drug manufacturer restrictions [...] …